MX9706725A - Mezclas enzimaticas definidas, novedosas para obtener celulas y para tratamientos de heridas. - Google Patents

Mezclas enzimaticas definidas, novedosas para obtener celulas y para tratamientos de heridas.

Info

Publication number
MX9706725A
MX9706725A MX9706725A MX9706725A MX9706725A MX 9706725 A MX9706725 A MX 9706725A MX 9706725 A MX9706725 A MX 9706725A MX 9706725 A MX9706725 A MX 9706725A MX 9706725 A MX9706725 A MX 9706725A
Authority
MX
Mexico
Prior art keywords
treating wounds
mixtures
enzyme mixtures
obtaining cells
new defined
Prior art date
Application number
MX9706725A
Other languages
English (en)
Other versions
MXPA97006725A (es
Inventor
Claus Otto Markert
Hans Thom
Juergen Weymann
Wolfgang Zahn
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19532906A external-priority patent/DE19532906A1/de
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of MX9706725A publication Critical patent/MX9706725A/es
Publication of MXPA97006725A publication Critical patent/MXPA97006725A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La presente invencion se refiere al uso de mezclas de composicion definida de enzimas purificadas de Clostridium histolyticum para obtener, en una forma reproducible y estandarizada, células o fragmentos de tejidos a partir de tejidos humanos o animales, y a esta enzimas y mezclas de esta; además se refiere al uso médico directo o indirecto de esta enzimas, solas o como ingredientes de mezclas, por ejemplo, en el tratamiento de heridas.
MXPA/A/1997/006725A 1995-03-16 1997-09-04 Mezclas enzimaticas definidas, novedosas para obtener celulas y para tratamientos de heridas MXPA97006725A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19509584 1995-03-16
DE19509584.7 1995-03-16
DE19532906.6 1995-09-07
DE19532906A DE19532906A1 (de) 1995-03-16 1995-09-07 Neue, definierte Enzymmischungen zur Zellgewinnung und für die Wundbehandlung
PCT/EP1996/001044 WO1996028543A1 (de) 1995-03-16 1996-03-12 Neue, definierte enzymmischungen zur zellgewinnung und für die wundbehandlung

Publications (2)

Publication Number Publication Date
MX9706725A true MX9706725A (es) 1997-11-29
MXPA97006725A MXPA97006725A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
WO1996028543A1 (de) 1996-09-19
CA2213723A1 (en) 1996-09-19
EA000583B1 (ru) 1999-12-29
US6146626A (en) 2000-11-14
IL117479A0 (en) 1996-07-23
NO974260D0 (no) 1997-09-15
JPH11501517A (ja) 1999-02-09
IL117479A (en) 1999-12-22
HUP9901188A2 (hu) 1999-08-30
CZ280397A3 (cs) 1998-04-15
NO974260L (no) 1997-11-14
AU5106696A (en) 1996-10-02
BR9607143A (pt) 1997-11-25
EA199700241A1 (ru) 1998-02-26
EP0815211A1 (de) 1998-01-07
AU702514B2 (en) 1999-02-25
PL322271A1 (en) 1998-01-19

Similar Documents

Publication Publication Date Title
MY117655A (en) Methods for treating hypercoagulable states or acquired protein c deficiency
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
EP0554383A4 (es)
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
NZ294446A (en) Stem cell proliferation inhibitors, haemoglobin chains used for the treatment of autoimmune diseases.
DE69920885D1 (en) C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)"
SE8902532D0 (sv) Bestaemning av plasmaproteiner
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
WO1999033979A3 (en) Bone marrow secreted proteins and polynucleotides
AU2522997A (en) Method for killing unwanted target cells
TR200200278T2 (tr) Kalsilitik bileşimler
EP0967276A3 (en) Anti-tumor agent comprising salmosin
ATE79265T1 (de) Mittel zur behandlung mykotischer, mikrobischer und anderer gewebsschaedigender und pathologischer manifestationen und gewebsdeformationen.
WO1998024482A3 (de) Verwendung von endothelin-konjugaten in der therapie, neue endothelin-konjugate, diese enthaltende mittel, sowie verfahren zu deren herstellung
WO1997040073A3 (de) BIOLOGISCH AKTIVER EIWEISSSTOFF - KOLLAGENFRAGMENT HF-COLL-18/514cf - ZUR HEMMUNG DES WACHSTUMS VON TUMOREN UND VON GEFÄSSWUCHERUNGEN
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
GB9723824D0 (en) Cytostatic agents
MD1222F1 (en) Process for obtaining a biological bandage of the skin
MD1270F1 (en) Method for treatment of the hand navicular bone pseudarthrosis
WO2000000161A3 (en) Methods for identification of tef-3 interacting factors
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
WO2000022097A3 (en) Periferal blood mensenchymal precursor cells
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози